These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15177547)

  • 21. Management of fistula-in-ano: 1990 Roussel Lecture.
    McLeod RS
    Can J Surg; 1991 Dec; 34(6):581-5. PubMed ID: 1747837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab treatment for anal fistula in patients with Crohn's disease.
    Higashi D; Futami K; Egawa Y; Hirano K; Tomiyasu T; Ishibashi Y; Simomura T; Nii K; Kuroki H; Maekawa T; Ono Y; Matsui T
    Anticancer Res; 2009 Mar; 29(3):927-33. PubMed ID: 19414329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Conservative therapy of fistulas of the anorectal area in Crohn disease].
    Peitz U; Brucks U; Malfertheiner P
    Zentralbl Chir; 1999; 124 Suppl 2():42-4. PubMed ID: 10544475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort.
    Pittet V; Juillerat P; Michetti P; Vader JP; Burnand B; Rogler G; Beglinger C; Seibold F; Mottet C; Felley C; Gonvers JJ; Froehlich F;
    Aliment Pharmacol Ther; 2010 Oct; 32(8):1007-16. PubMed ID: 20937046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic strategies of fistulous Crohn's disease: medical or surgical treatment?].
    Bouhnik Y; Panis Y
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S98-103. PubMed ID: 12704303
    [No Abstract]   [Full Text] [Related]  

  • 27. Fistula treatment: The unresolved challenge.
    Vavricka SR; Rogler G
    Dig Dis; 2010; 28(3):556-64. PubMed ID: 20926886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal diversion in perirectal fistulizing Crohn's disease is an underutilized and potentially temporary means of successful treatment.
    Rehg KL; Sanchez JE; Krieger BR; Marcet JE
    Am Surg; 2009 Aug; 75(8):715-8. PubMed ID: 19725296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Optimizing treatment of complicated forms of inflammatory bowel disease. Fistulizing Crohn's disease].
    Peñate M; Cruz-Santamaría M; Mendoza JL; Peña AS; Díaz-Rubio M; García-Paredes J
    An Med Interna; 2003 Jan; 20(1):37-45. PubMed ID: 12666309
    [No Abstract]   [Full Text] [Related]  

  • 31. [Surgical treatment of anal fistulas in Crohn's disease].
    Heyckendorff-Diebold T; Maeda Y; Buntzen S; Lundby L
    Ugeskr Laeger; 2012 Sep; 174(38):2219-22. PubMed ID: 22992478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perianal fistulizing Crohn's disease: a call to action.
    Kamm MA; Ng SC
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):7-10. PubMed ID: 18063415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies.
    Plamondon S; Ng SC; Kamm MA
    Aliment Pharmacol Ther; 2007 Mar; 25(5):557-67. PubMed ID: 17305756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statement of the expert group on the current practice and prospects for the treatment of complex perirectal fistulas in the course of Crohn's disease.
    Banasiewicz T; Eder P; Rydzewska G; Reguła J; Dobrowolska A; Durlik M; Wallner G
    Pol Przegl Chir; 2019 Feb; 91(1):38-46. PubMed ID: 30919811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of fibrostenotic and fistulizing Crohn's disease.
    Schoepfer AM; Safroneeva E; Vavricka SR; Peyrin-Biroulet L; Mottet C
    Digestion; 2012; 86 Suppl 1():23-7. PubMed ID: 23051723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of fistulizing Crohn's disease.
    Lichtenstein GR
    Gastroenterology; 2000 Oct; 119(4):1132-47. PubMed ID: 11040200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical management of anorectal complications in Crohn disease].
    Winkler R
    Zentralbl Chir; 1998; 123(4):362-7. PubMed ID: 9622895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Horseshoe tract of anal fistula: bad luck or an avoidable extension? Lessons from 82 cases.
    de Parades V; Fathallah N; Blanchard P; Zeitoun JD; Bennadji B; Atienza P
    Colorectal Dis; 2012 Dec; 14(12):1512-5. PubMed ID: 22443225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4+CD161+ T lymphocytes infiltrate Crohn's disease-associated perianal fistulas and are reduced by anti-TNF-α local therapy.
    Maggi L; Capone M; Giudici F; Santarlasci V; Querci V; Liotta F; Ficari F; Maggi E; Tonelli F; Annunziato F; Cosmi L
    Int Arch Allergy Immunol; 2013; 161(1):81-6. PubMed ID: 23257766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Algorithm for the treatment of Crohn's disease: incorporation of emerging therapies.
    Souney PF
    Am J Gastroenterol; 2000 Sep; 95(9):2381-3. PubMed ID: 11007248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.